Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
This product will be manufactured at Lupin’s Pithampur facility In India
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
The investment will increase SpeeDx internal capacity to scale up manufacturing
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
Subscribe To Our Newsletter & Stay Updated
